| AE | Adverse event |
| DPP4i | Dipeptidyl peptidase-4 inhibitor |
| CI | Confidence interval |
| FAERS | Food and Drug Administration Adverse Events Reporting System |
| ISR | Injection-site reaction |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GLP-1 RA | Glucagon-like peptide 1 receptor agonist |
| RCT | Randomized controlled trial |
| RR | Relative risk |
| ROR | Reporting odds ratio |
| T2DM | Type 2 diabetes |
| SGLT2i | Sodium-glucose cotransporter-2 inhibitor |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.